Sort   by:  
 Page size 
Proteomic technology was used to identify the components of CatSper complex.
ORGANISM(S): Mus Musculus (ncbitaxon:10090) 
2021-04-28 | MSV000087325 | MassIVE
Clinical trials have demonstrated that CXCR4 antagonists enhance the efficacy of immunotherapy in cancers by reducing regulatory T (Treg) cells, elucidating how certain mechanisms of CXCR4 in affecting Treg cells are essential for developing immunotherapeutic strategies.
ORGANISM(S): Homo Sapiens 
2024-11-25 | PXD058262 |
Sort   by:  
 Page size